Effect of a cheese rich in angiotensin-converting enzyme-inhibiting peptides (Gamalost®) and a Gouda-type cheese on blood pressure: results of a randomised trial
Background: High blood pressure (BP) is the leading risk factor for global disease burden, contributing to 7% of global disability adjusted life years. Angiotensin converting enzyme (ACE)-inhibiting bioactive peptides have the potential to reduce BP in humans. These peptides have been identified in...
Main Authors: | Rita Nilsen, Are H. Pripp, Arne T. Høstmark, Anna Haug, Siv Skeie |
---|---|
Format: | Article |
Language: | English |
Published: |
Swedish Nutrition Foundation
2016-08-01
|
Series: | Food & Nutrition Research |
Subjects: | |
Online Access: | http://www.foodandnutritionresearch.net/index.php/fnr/article/view/32017/48112 |
Similar Items
-
Effect of a high intake of cheese on cholesterol and metabolic syndrome: results of a randomized trial
by: Rita Nilsen, et al.
Published: (2015-08-01) -
Comparison of Physicochemical and Sensory Properties between Cholesterol-removed Gouda Cheese and Gouda Cheese during Ripening
by: Ho-Jung Jung, et al.
Published: (2013-12-01) -
Metagenomics of pasteurized and unpasteurized gouda cheese using targeted 16S rDNA sequencing
by: Joelle K. Salazar, et al.
Published: (2018-11-01) -
Survival and Growth of Bacillus cereus during Gouda cheese manufacturing
by: Rukure, Grace Tapiwa
Published: (2013) -
Pediococci in South African Cheddar and Gouda cheese
by: Kau, Reginah Nki
Published: (2013)